|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Net revenue | |||||
| Cost of revenue | |||||
| Gross profit | |||||
| Operating expenses: | |||||
| Research and development | |||||
| Sales and marketing | |||||
| General and administrative | |||||
| Litigation reserves, net | |||||
| Restructuring and other charges | |||||
| Goodwill impairment | |||||
| Intangible assets impairment | |||||
| Other operating expenses, net | |||||
| Total operating expenses | |||||
| Income (loss) from operations | |||||
| Other income, net | |||||
| Income (loss) before income taxes | |||||
| Provision for income taxes | |||||
| Net income (loss) | |||||
| Net income (loss) per share | |||||
| Basic | |||||
| Diluted | |||||
| Weighted average shares used to compute net income (loss) per share: | |||||
| Basic | |||||
| Diluted |
Loading...
